DOI QR코드

DOI QR Code

Narcotics and Psychostimulants in Acute Overdose-Suspected Patients in Emergency Departments in Korea: Analysis of Toxicological Laboratory Data

응급실 내원 중독의심환자에서 마약류 검출: 중독분석실 생체시료 분석결과

  • Yoonsoo Kim (Department of Emergency Medicine, National Medical Center) ;
  • Jiwon Lee (Department of Emergency Medicine, National Medical Center) ;
  • Suncheun Kim (National Forensic Service) ;
  • Arum Lee (Emergency Medicine Center, National Medical Center) ;
  • Misuk Kim (Emergency Medicine Center, National Medical Center) ;
  • Yun Hee Kim (Emergency Medicine Center, National Medical Center) ;
  • Jung-In Ko (Department of Emergency Medicine, National Medical Center) ;
  • Bum Jin Oh (Department of Emergency Medicine, National Medical Center)
  • 김윤수 (국립중앙의료원 응급의학과) ;
  • 이지원 (국립중앙의료원 응급의학과) ;
  • 김선춘 (국립과학수사연구원) ;
  • 이아름 (국립중앙의료원 중앙응급의료센터) ;
  • 김미숙 (국립중앙의료원 중앙응급의료센터) ;
  • 김윤희 (국립중앙의료원 중앙응급의료센터) ;
  • 고정인 (국립중앙의료원 응급의학과) ;
  • 오범진 (국립중앙의료원 응급의학과)
  • Received : 2024.11.11
  • Accepted : 2025.01.18
  • Published : 2025.06.30

Abstract

Purpose: Narcotic use and associated overdose deaths pose a serious public health threat worldwide. The use of psychostimulants, amphetamines and their derivatives, methamphetamine, ecstasy, or 3,4-methylenedioxy-methamphetamine (MDMA) is a significant challenge to the emergency department (ED). Although cases of illicit psychostimulant use have been reported in Korea, no reports with confirmative laboratory analyses have been reported. The objective of this study was to present data on ED patients who have used psychostimulants. Methods: We used the 2019-2022 toxicological laboratory database of the National Medical Center, which includes data from six nationwide toxicological laboratories that support suspected acute poisoning patients in the ED. We analyzed demographics (age and sex), presenting mental status, and ethanol co-ingestion. The psychostimulant group was compared with the narcotic group, which contained patients who consumed narcotic drugs but not psychostimulants. Results: Among 4,366 patients, narcotic drugs were detected in 2,239 patients (51.3%): 2,176 in the narcotic group, one who used cannabis, and 60 in the psychostimulant group. Psychostimulant cases were reported from 2019 to 2022 (13, 11, 25, and 11 each year). The psychostimulant group was younger (39.3±14.3 vs. 55.3±21.5 years), contained more female patients (45.0% vs. 21.1%), and had poorer mental status than the narcotic group (p<0.01). The cases of psychostimulant use were treated in 26 hospitals throughout Korea. Conclusion: This is the first study reporting results from confirmative analyses of narcotic drug use in ED patients. Psychostimulant-related ED visits were observed throughout Korea.

Keywords

References

  1. Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BD, et al. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet 2019;394:1560-79. https://doi.org/10.1016/S0140-6736(19)32229-9
  2. Humphreys K, Shover CL, Andrews CM, Bohnert AS, Brandeau ML, Caulkins JP, et al. Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission. Lancet 2022;399:555-604. https://doi.org/10.1016/S0140-6736(21)02252-2
  3. Kim S. Current status of drug addiction in Korea: focusing on case analysis. Proc Korean Soc Emerg Med [Internet] 2023 [cited 2024 Nov 5];2023:113. Available from: https://kiss.kstudy.com/Detail/Ar?key= 4015000
  4. U.S. Department of Justice, Drug Enforcement Administration, Diversion Control Division. Controlled Substance Schedules [Internet]. Springfield (VA): U.S. Department of Justice; c2024 [cited 2024 Nov 5]. Available from: https://www.deadiversion.usdoj.gov/schedules/schedules.html
  5. Centers for Disease Control and Prevention, Health Alert Network (HAN) Health Advisory. Increase in fatal drug overdoses across the United States driven by synthetic opioids before and during the COVID-19 pandemic: HAN00438 [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2020 [cited 2024 Nov 5]. Available from: https://archive.cdc.gov/emergency_cdc_gov/han/2020/han00438.asp
  6. Crispo JA, Liu L, Bach P, Ansell DR, Sivapathasundaram B, Nguyen F, et al. Amphetamine-related emergency department visits in Ontario, Canada, 2003-2020. Can J Psychiatry 2023; 68:838-49. https://doi.org/10.1177/07067437231158933
  7. Tardelli VS, Johnstone S, Xu B, Kim S, Kim HK, Gratzer D, et al. Marked increase in amphetamine-related emergency department visits and inpatient admissions in Toronto, Canada, 2014-2021. Can J Psychiatry 2023;68:249-56. https://doi.org/10.1177/07067437221125302
  8. Choi NG, Choi BY, Marti CN, DiNitto DM, Baker SD. Substance use and medical outcomes in those age 50 and older involving cocaine and metamfetamine reported to United States poison centers. Clin Toxicol (Phila) 2023;61:400-7. https://doi.org/10.1080/15563650.2023.2185494
  9. Jones CM, Houry D, Han B, Baldwin G, Vivolo-Kantor A, Compton WM. Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction. Ann N Y Acad Sci 2022;1508:3-22. https://doi.org/10.1111/nyas.14688
  10. Amaducci A, Aldy K, Campleman SL, Li S, Meyn A, Abston S, et al. Naloxone use in novel potent opioid and fentanyl overdoses in emergency department patients. JAMA Netw Open 2023;6:e2331264. https://doi.org/10.1001/jamanetworkopen.2023.31264
  11. Kim IS. Strengthening drug safety management in response to the change in drug management paradigm [Internet]. Cheongju: Ministry of Food and Drug Safety; 2022 [cited 2024 Nov 5]. Available from: https://www.mfds.go.kr/docviewer/skin/doc.html?fn=20221102020800811.pdf&rs=/docviewer/result/cmnt0019/414/1/202309
  12. Caraci F, Enna SJ, Zohar J, Racagni G, Zalsman G, van den Brink W, et al. A new nomenclature for classifying psychotropic drugs. Br J Clin Pharmacol 2017;83:1614-6. https://doi.org/10.1111/bcp.13302
  13. Korea Pharmaceutical Information Center. Narcotics [Internet]. Seoul: Korea Pharmaceutical Information Center; 2000 [cited 2024 Nov 5]. Available from: https://www.health.kr/Menu.PharmReview/View.asp?PharmReview_IDX= 8501
  14. Macintyre PE, Quinlan J, Levy N, Lobo DN. Current issues in the use of opioids for the management of postoperative pain: a review. JAMA Surg 2022;157:158-66. https://doi.org/10.1001/jamasurg.2021.6210
  15. Cho NR, Chang YJ, Lee D, Kim JR, Ko DS, Choi JJ. Trends in opioid prescribing practices in South Korea, 2009-2019: are we safe from an opioid epidemic? PLoS One 2021;16: e0250972. https://doi.org/10.1371/journal.pone.0250972
  16. Yoon SH, Kim J, Yoon S, Lee HJ. Current status of opioid prescription in South Korea using narcotics information management system. Korean J Pain 2024;37:41-50. https://doi.org/10.3344/kjp.23234
  17. National Center for Mental Health. The survey of drug users in Korea 2021 [Internet]. Seoul: National Center for Mental Health; 2021 [cited 2024 Nov 5]. Available from: https://mhs.ncmh.go.kr/research/4?mid= a10201000000&seq=15
  18. Casillas SM, Scholl L, Mustaquim D, Vivolo-Kantor A. Analysis of trends and usage of ICD-10-CM discharge diagnosis codes for poisonings by fentanyl, tramadol, and other synthetic narcotics in emergency department data. Addict Behav Rep 2022;16:100464. https://doi.org/10.1016/j.abrep.2022.100464
  19. Dragomir L, Marina V, Anghele M, Anghele AD, Moscu CA. Incidence of intoxications in the emergency department of Galati Hospital with examples of cardiovascular effects of MDMA intoxication. Diagnostics (Basel) 2023;13:940. https://doi.org/10.3390/diagnostics13050940
  20. Lee SK, Choi S. Availability of urine toxicologic screening tests in the emergency department: focused on illegal drugs. J Korean Soc Clin Toxicol 2021;19:24-30. https://doi.org/10.22537/jksct.2021.19.1.24
  21. Park M, Choi H, Choi S, Son H, Lim M, Chung H. Cross-reactivity of Amphetamine analogues in various immunoassays. Yakhak Hoeji [Internet] 2003 [cited 2024 Nov 5];47:266-70. Available from: https://www.koreascience.or.kr/article/JAKO200311922266114.pdf
  22. Holland KM, Jones C, Vivolo-Kantor AM, Idaikkadar N, Zwald M, Hoots B, et al. Trends in US emergency department visits for mental health, overdose, and violence outcomes before and during the COVID-19 pandemic. JAMA Psychiatry 2021;78:372-9. https://doi.org/10.1001/jamapsychiatry.2020.4402
  23. Kevil CG, Goeders NE, Woolard MD, Bhuiyan MS, Dominic P, Kolluru GK, et al. Methamphetamine use and cardiovascular disease. Arterioscler Thromb Vasc Biol 2019;39:1739-46. https://doi.org/10.1161/ATVBAHA.119.312461
  24. Suen LW, Davy-Mendez T, LeSaint KT, Riley ED, Coffin PO. Emergency department visits and trends related to cocaine, psychostimulants, and opioids in the United States, 2008-2018. BMC Emerg Med 2022;22:19. https://doi.org/10.1186/s12873-022-00573-0
  25. Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, et al. 2022 Annual Report of the National Poison Data System(R) (NPDS) from America's Poison Centers(R): 40th Annual Report. Clin Toxicol (Phila) 2023;61:717-939. https://doi.org/10.1080/15563650.2023.2268981
  26. Vivolo-Kantor AM, Hoots BE, Seth P, Jones CM. Recent trends and associated factors of amphetamine-type stimulant overdoses in emergency departments. Drug Alcohol Depend 2020;216:108323. https://doi.org/10.1016/j.drugalcdep.2020.108323
  27. Thompson JP, Watson ID, Thanacoody HK, Morley S, Thomas SH, Eddleston M, et al. Guidelines for laboratory analyses for poisoned patients in the United Kingdom. Ann Clin Biochem 2014;51(Pt 3):312-25. https://doi.org/10.1177/0004563213519754
  28. Hepler BR, Sutheimer CA, Sunshine I. Role of the toxicology laboratory in the treatment of acute poisoning. Med Toxicol 1986;1:61-75. https://doi.org/10.1007/BF03259828